Cutaneous Lupus Erythematosus Clinical Trial
Official title:
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Studies have shown that there are significant differences in severity and outcome of lupus in patients of colored skin compared with Caucasians. There are many factors that lead to this discrepancy: genetics, poverty, education level, as well as behavioral and cultural factors. Cutaneous Lupus Erythematosus (CLE) is a disease of flares and remissions with identifiable triggers. One of the most aggravating triggers in CLE is sun exposure. The investigators hypothesize that there are disparities in knowledge about photoprotection, leading to poorer outcomes in minority ethnic groups. This study aims to assess knowledge of risk factors and triggers, especially sun exposure, and the effects on quality of life of Caucasian and minority populations, by conducting an assessment survey and subsequent teaching intervention on appropriate skin protection techniques including appropriate sun screen application, and use of sun-protective clothing. After three months a survey to evaluate knowledge retention about and the application of the educational intervention will be conducted.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01776190 -
Low-dose UVA1 Radiation in Cutaneous Lupus Patients
|
N/A | |
| Completed |
NCT00420173 -
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
|
N/A | |
| Terminated |
NCT04809623 -
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
|
Phase 1 | |
| Completed |
NCT01300208 -
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
|
Phase 2 | |
| Terminated |
NCT01470313 -
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT01146444 -
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)
|
N/A | |
| Not yet recruiting |
NCT06015737 -
A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
|
Phase 3 | |
| Completed |
NCT03134222 -
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
|
Phase 2 | |
| Completed |
NCT00470912 -
Sunscreen RV 2457C in Photoinduced CLE
|
Phase 3 | |
| Completed |
NCT01841619 -
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
|
Phase 0 | |
| Completed |
NCT00523588 -
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
|
Phase 2 | |
| Terminated |
NCT01498406 -
Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
|
Phase 2 | |
| Completed |
NCT04647708 -
Study of M5049 in CLE and SLE Participants
|
Phase 1 | |
| Completed |
NCT03817424 -
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
|
Phase 1 | |
| Active, not recruiting |
NCT03260166 -
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT00317681 -
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
|
Phase 2 | |
| Completed |
NCT04781816 -
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
|
Phase 2 |